What evidence supports the use of Impella CP with SmartAssist for temporary left ventricular support in cardiogenic shock and protected high-risk percutaneous coronary intervention in patients with severely reduced left ventricular function?
No direct evidence for Impella CP with SmartAssist was identified in patients with severe left ventricular dysfunction. Indirect evidence from studies on similar devices suggests potential benefits but highlights significant safety concerns, necessitating further research.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-04
- DOI
- https://doi.org/10.5281/zenodo.23937978
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.00